The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hope we are aiming for something more significant than a scientific poster. How about a case study on the five patients presented already. Hey we might be considering writing a full paper although with AS in charge we will go for something with a 12 month publication lead time.
Since I'm lazy does anyone know when the closing date for late breaker Abstract is - might even get a presentation
£1.87 incoming
:-)
Is the share price correlated with the number of posts from the pom pom shakers on twitter. Quality certainly is. Very disappointing efforts of late with individual share purchasers and clubs from old news dominating. Worst of it when one of them personally predicts something which from past performance enables everyone else to be confident it won't.
I suggest regular breaks - perhaps limiting it to one post an hour and weaning off it until one tweet a day feels excessive.
Just a thought.
I've heard Tom Thumb is taking the minutes whilst RAH is standing by with the magic calculator.
You would think he'd do a recorded interview with Mr 9 questions from the agm. Whilst it risks leading the AS horse to water the bloke has more understanding of the nuances and seems to be a genuine LTH with a bit more interest in other SH than a second hand, third rate analyst on the make.
I'd like to say what a professional communications strategy we have. No wonder SP is where it is - sends the wrong signals and I'm gobsmacked chairman allows it - don't need to be boosters when tea and stickies with pump and dump is how you present the company to the investment community.
From memory isn't this just a rehash of the meeting that never was. AS touted to meet Mr McPumpy but the turned out it never happened.
To be fair some good questions emerging - would just hope Avacta a bit more confident about the answers and possible gaps than the coffee morning approach would suggest.
I suspect its all part of the next wave of ramping due to start a couple of weeks before the large cancer meeting. 10% gang will be out in full force and the filtered output from tea and stickies would help the cause. Hopefully the news will be so good that AS will have to forgo the chocolate digestives and let them pump on their own.
PL75 said it spot on. We have had a few presentations where questions were requested and then ignored. The last one went over and above and has a standard investor I was pleased with that.
I'd go with quarterly updates of that standard.
I question the professional standards were the company to go along with the ego stroke especially of an investor so active in pumping and then dumping the company stock whilst also advising other investors.
Oh hang on.....
OK bit of a sloooow descent up from the hyped data presentation. We know data likely to be presented in April.
Plan from here is to turn off the pom pom shaking until early March. Go back through the data and recharge the magic calculator to max. Stock up on stock from now until late Feb.
Then hit twitter with everything until the April presentation. Looks like McP was a bit premature on the plan rebuying from the last pump a tadge early but timing is never easy. Expect new multipage hypothesis about W1 in March.
Energy shares :-).
Non issue raised by the tw4tterati who then just amplify it as if 4 people repeating nonsense is evidence. You either believe management are capable and the Dx strategy is brilliance in the making and therefore their ability adds value to therapeutics. The alternative is they have thrown away millions in hard needed cash and don't have the smarts required by Tx and should be replaced. The pom pom guys would have us belive losing millions on a vanity project is excellent justification for believing they can make them all rich. Management would be resigning if they went down that path. Sometimes when you have nothing to say then shut up rather than just putting stuff into the magic calculator and parroting it.
The company have stated they will have cash required soon. They state that deals on precision are in the making.
No worries.
Pseudoscience ---- from the child with the crayons.
Careful you don't fall from your self erected pedestal
Oh hang on I've just checked the slides on the Avacta website and it's too late. Managed to miss the key data and none of your insight actually happened. Oh dear. Same science brilliance that led you to pump 4D pharma and your mining shares. Data is in and doesn't look great for you.
I get that SP is right for a bit of pump and dump - poetic that you are back. Try being humble. You have a lot.....
Did you see what I did there :-)
Bring back the timeline. Oh and the funny graph done with crayons. Now the self help circle has booted out the over enthusiastic thrashing, twitter is overwhelmed by pom pom girls and the need for pantomime donkeys is over for another year, we can expect more self pitying clip clop of tiny man hooves.
If only there was some way of commercialising the IP inherent in affimer technology the SP could respond. I just hope that Avacta don't try and rush this to market and in so doing jeopardise the chance of further posters in basic science journals.
It's still a log scale. Cmax and AUC differences are huge. Not sure if this discussion reflects true numbers.
The pk graph is on a log scale.